Blueprint ID | Learning Objectives |
8619 | Describe the functions of cell-mediated immunity (CMI) and the consequences of a deficiency in CMI |
8620 | Describe the functions of antibody-mediated (humoral) immunity and the consequences of this type of deficiency |
8621 | Discuss the approach to the differentiation between deficiencies of humoral immunity, CMI, phagocyte cell function, and complement. |
8622 | List the different types of antibody-mediated immune deficiencies |
8623 | Describe the consequences of combined immune deficiency |
8624 | Recognize germinal centres |
8625 | Interpret results from the following lab tests: |
8626 | Measurement of serum immunoglobulins |
8627 | Measurement of antibody titers, i.e., enzymoimmunoassay, complement fixation, and 50% viral plaque reduction assay |
8628 | Measurement of "natural" blood group antibody (isoagglutinins) |
8629 | Measurement of hemolytic complement activity (CH50) |
8630 | Skin testing with mumps antigen, purified-protein derivative (PPD) of tuberculin, histoplasmin, Candida antigens, and tetanus toxoid |
8631 | Phytohemagglutinin (PHA) stimulation of peripheral blood lymphocytes |
8632 | Measurement of antibodies to pneumococcal polysaccharides |
8633 | Enumeration of lymphocyte subsets by flow cytometry |
| |